Adc Therapeutics Sa Stock In The News
| ADCT Stock | USD 1.94 0.04 2.02% |
Our overall analysis of ADC Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards ADC Therapeutics SA. The specific impact of ADC Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ADC Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ADC Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out ADC Therapeutics Backtesting and ADC Therapeutics Hype Analysis.
ADC |
ADC Therapeutics Today Top News and Investor Outlook
ADC Therapeutics SA Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ADC and other traded companies coverage with news coverage. We help investors stay connected with ADC headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on ADC Stock performance. Please note that trading solely based on the ADC Therapeutics SA hype is not for everyone as timely availability and quick action are needed to avoid losses.
ADC Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ADC earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ADC Therapeutics that are available to investors today. That information is available publicly through ADC media outlets and privately through word of mouth or via ADC internal channels. However, regardless of the origin, that massive amount of ADC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADC Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADC Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADC Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADC Therapeutics alpha.
ADC Largest EPS Surprises
Earnings surprises can significantly impact ADC Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.38 | -0.42 | -0.04 | 10 | ||
2023-05-09 | 2023-03-31 | -0.67 | -0.74 | -0.07 | 10 | ||
2024-08-06 | 2024-06-30 | -0.46 | -0.38 | 0.08 | 17 | ||
2021-08-03 | 2021-06-30 | -0.86 | -0.96 | -0.1 | 11 | ||
2023-08-08 | 2023-06-30 | -0.46 | -0.58 | -0.12 | 26 | ||
2020-06-03 | 2020-03-31 | -0.56 | -0.77 | -0.21 | 37 |
ADC Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ADC Therapeutics Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
19th of November 2024
ADC Therapeutics SA Short Interest Down 9.7 percent in October at thelincolnianonline.com
14th of November 2024
ADC Therapeutics Shareholders Approve Amendments to Capital Structure in Special Meeting at thelincolnianonline.com
8th of November 2024
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100 percent Upside - H... at finance.yahoo.com
7th of November 2024
ADC Therapeutics SA Reports Q3 Loss, Lags Revenue Estimates at finance.yahoo.com
6th of November 2024
What To Expect From ADC Therapeutics SA Q3 2024 Earnings at gurufocus.com
5th of November 2024
Antibody Drug Conjugates Industry Report 2024 - Advancements in Payload and Linker Technol... at finance.yahoo.com
4th of November 2024
Lonzas Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learn... at finance.yahoo.com
28th of October 2024
Institutional investors own a significant stake of 32 percent in ADC Therapeutics SA at finance.yahoo.com
24th of September 2024
Bank of New York Mellon Corp Buys Shares of 205,221 ADC Therapeutics SA - MarketBeat at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADC Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADC Therapeutics' short interest history, or implied volatility extrapolated from ADC Therapeutics options trading.
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.